Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions

Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions

IntroductionProstate cancer is one of the most common malignant tumors in Chinese men, which is rich in iron metabolic activity and is closely related to all stages of prostate cancer progression. Since the current diagnostic methods are insufficient, we aimed to evaluate the value of quantitative T...

Full description

Bibliographic Details
Main Authors:	Wenhao D, Guangzheng L, Zhen T, Xuedong W, Yonggang L, Xuefeng Z, Weijie Z, Gang L, Yuhua H
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer PI-RADS iron mentalism multiparametric magnetic resonance imaging diagnosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1185057/full

Similar Items

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
by: Paulius Aliukonis, et al.
Published: (2017-04-01)

Predictors of prostate cancer cetection in MRI PI-RADS 3 lesions – Reality of a terciary center
by: Débora Araújo, et al.
Published: (2023-12-01)

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
by: Guan-Hui Cai, et al.
Published: (2021-05-01)

Magnetic resonance semiotics of prostate cancer according to the PI-RADS classification. The clinical diagnostic algorithm of a study
by: A. S. Korobkin, et al.
Published: (2016-03-01)

PI‐RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
by: Andrés Camacho, et al.
Published: (2023-07-01)

Biparametric Prostate MRI Shows Similar Diagnostic Accuracy Rates for Prostate Cancer Detection with Multiparametric MRI
by: Faruk Yencilek, et al.
Published: (2022-09-01)

Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions
by: Pietro Andrea Bonaffini, et al.
Published: (2023-10-01)

Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions
by: Michela Gravina, et al.
Published: (2022-06-01)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
by: Tong Chen, et al.
Published: (2022-01-01)

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
by: Caterina Gaudiano, et al.
Published: (2023-02-01)

Prostate Imaging Reporting and Data System (PI-RADS) v 2.1: Overview and Critical Points
by: Chan Kyo Kim
Published: (2023-01-01)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
by: Yu-Hao Wang, et al.
Published: (2023-01-01)

Impact of Chronic Prostatitis on the PI-RADS Score 3: Proposal for the Addition of a Novel Binary Suffix
by: Sascha Merat, et al.
Published: (2021-03-01)

Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
by: Caleb Natale, et al.
Published: (2021-12-01)

The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting
by: Yannic Volz, et al.
Published: (2023-08-01)

Development and internal validation of PI-RADs v2-based model for clinically significant prostate cancer
by: Yu Zhang, et al.
Published: (2018-06-01)

Comparison of Diagnostic Performance Between PI-RADS v2.1 and PI-RADS v2 for Prostate Cancer: A Meta-analysis
by: BAI Guojie, et al.
Published: (2023-10-01)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
by: Tianping Li, et al.
Published: (2022-01-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01)

Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?
by: Enrique Gomez-Gomez, et al.
Published: (2021-07-01)

Multiparametric MRI and MR Spectroscopic Imaging of Prostate Lesions with Implementation of PI-RADS and Histopathological Correlation: A Prospective Analysis
by: Reddy Ravikanth, et al.
Published: (2019-01-01)

Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogram
by: Yongbing Cheng, et al.
Published: (2024-04-01)

Prevalence of Bladder Cancers Incidentally Detected During Multiparametric MRI Scans of the Prostate Gland and the Clinical Significance of Scoring Them According to VI-RADS: A Pictorial Single-Centre Study
by: Ramazan Orkun Onder, et al.
Published: (2024-02-01)

Intraobserver and Interobserver Agreement between Six Radiologists Describing mpMRI Features of Prostate Cancer Using a PI-RADS 2.1 Structured Reporting Scheme
by: Rafał Jóźwiak, et al.
Published: (2023-02-01)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
by: Jing Wen, et al.
Published: (2022-04-01)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
by: Daniël F. Osses, et al.
Published: (2020-12-01)

Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone
by: Ying-Ying Zhao, et al.
Published: (2023-11-01)

Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies
by: Richard A. Hsi, et al.
Published: (2023-01-01)

The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
by: Marcin Miszczyk, et al.
Published: (2022-03-01)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
by: Chung-Un Lee, et al.
Published: (2022-08-01)

Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions
by: Bastian Keck, et al.
Published: (2021-05-01)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
by: Rui Su, et al.
Published: (2022-07-01)

In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
by: Jihae An, et al.
Published: (2021-08-01)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
by: Julie Y. An, et al.
Published: (2017-10-01)

Primary follicular lymphoma of the prostate co-existing with grade group 5 prostatic adenocarcinoma and presenting as a PI-RADS lesion 4 on mpMRI
by: Shubhneet Bal, et al.
Published: (2024-05-01)

Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging
by: Wanxian Nong, et al.
Published: (2023-11-01)

Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions
by: Changwei Yuan, et al.
Published: (2023-11-01)

Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
by: Jinxing Yu, et al.
Published: (2020-06-01)

Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner
by: Abdallah Sharqawi, et al.
Published: (2023-04-01)

Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer
by: Sarang M. Ingole, et al.
Published: (2021-01-01)